Bromoacetylalprenololmenthane
Names | |
---|---|
IUPAC name
2-bromo-N-[2-[4-[[2-hydroxy-
3-(2-prop-2-enylphenoxy)propyl]amino]-
4-methylcyclohexyl]propan-2-yl]acetamide | |
Identifiers | |
76298-89-0 82870-40-4 | |
Abbreviations | BrAAM |
ChEMBL | ChEMBL46136 |
ChemSpider | 112852 |
Jmol interactive 3D | Image Image |
MeSH | Bromoacetylalprenololmenthane |
PubChem | 127126 |
| |
| |
Properties | |
C24H37BrN2O3 | |
Molar mass | 481.48 g·mol−1 |
log P | 4.14 |
Acidity (pKa) | 13.844 |
Basicity (pKb) | 0.153 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Bromoacetylalprenololmenthane (BAAM) is a beta-adrenergic agonist.[2]
References
- ↑ BrAAM - Compound Summary, PubChem.
- ↑ Rainer-Joachim; Matthys Staehelin (20 April 1987). "Bromoacetylalprenololmenthane binding to β-receptors modulates the rate of hormone-induced internalization but not desensitization in S49 cells". FEBS Letters 214 (2): 323–326. doi:10.1016/0014-5793(87)80079-0.
This article is issued from Wikipedia - version of the Wednesday, June 24, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.